Vantage Communications becomes agency of record for ImThera Medical

NewsGuard 100/100 Score

Vantage Communications, an award-winning global PR firm, today announced that it is the agency of record for ImThera Medical, Inc. Within a few months, Vantage Communications successfully promoted ImThera and its medical device technology with original coverage garnered in top-tier publications such as Neurotech Insights, ENToday, The Gray Sheet, Sleep Review, Respiratory & Sleep Management, Respiratory Therapy, Medical Device Daily, and medGadget. Additionally, mainstream coverage appeared in Technology Review, CNET, and Xconomy.

“The partnership between Vantage Communications and ImThera is representative of the agency expanding its practice into healthcare and medical technology. We are honored to have ImThera Medical on board as part of our medical device technology practice and we look forward to helping them realize increased success.”

As an early-stage company, ImThera required an experienced media relations team to quickly assist with its launch and to unveil its neurostimulation medical device for the treatment of Obstructive Sleep Apnea (OSA). Marcelo Lima, chairman, president and CEO of ImThera Medical, says, "We wanted to introduce ImThera to the world with a strong impact so we had high expectations for the PR agency we selected." He adds, "As a direct result of the media coverage we've received, we saw significant spikes with the web traffic to our site. When the CNET article appeared online, for example, the ImThera website experienced an immediate 82% increase in traffic."

"As the medical device market continues to grow, we're pleased to help ImThera Medical gain exposure in the right places with its innovative offering," said Ilene Adler, CEO and president of Vantage Communications. "The partnership between Vantage Communications and ImThera is representative of the agency expanding its practice into healthcare and medical technology. We are honored to have ImThera Medical on board as part of our medical device technology practice and we look forward to helping them realize increased success."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Hypoglossal nerve stimulation offers hope for pediatric Down syndrome patients with OSA